US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

IMAB

I MAB (IMAB)

I MAB

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/06	20 : 14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/06/06	20 : 00	PR Newswire (US)	I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	NASDAQ:IMAB	I MAB
2024/06/05	20 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/06/05	20 : 00	PR Newswire (US)	I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	NASDAQ:IMAB	I MAB
2024/05/31	06 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IMAB	I MAB
2024/05/24	06 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/05/24	06 : 05	GlobeNewswire Inc.	I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024	NASDAQ:IMAB	I MAB
2024/05/22	20 : 00	PR Newswire (US)	I-Mab to Participate at the Jefferies Global Healthcare Conference	NASDAQ:IMAB	I MAB
2024/04/30	20 : 00	PR Newswire (US)	I-MAB Filed 2023 Annual Report on Form 20-F	NASDAQ:IMAB	I MAB
2024/04/05	20 : 00	PR Newswire (US)	I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:IMAB	I MAB
2024/04/03	05 : 01	PR Newswire (US)	I-Mab Announces Closing of the Divestiture of Business Operations in China	NASDAQ:IMAB	I MAB
2024/03/15	06 : 00	PR Newswire (US)	I-Mab Reports Full Year 2023 Financial Results and Business Update	NASDAQ:IMAB	I MAB
2024/02/10	06 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMAB	I MAB
2024/02/08	20 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2024/02/07	20 : 52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/02/07	20 : 00	PR Newswire (US)	I-Mab Signs Agreement to Divest its Assets and Business Operations in China	NASDAQ:IMAB	I MAB
2024/02/07	10 : 55	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:IMAB	I MAB
2024/02/06	20 : 34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/01/05	20 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2024/01/03	07 : 08	Dow Jones News	ADRs Slump; FLJ Group Declines 21%	NASDAQ:IMAB	I MAB
2023/12/29	20 : 12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/12/26	20 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/12/02	04 : 41	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:IMAB	I MAB
2023/11/16	20 : 43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/11/06	22 : 00	PR Newswire (US)	I-Mab Announces Participation at Jefferies and Piper Conferences in November	NASDAQ:IMAB	I MAB
2023/11/02	21 : 00	PR Newswire (US)	Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)	NASDAQ:IMAB	I MAB
2023/11/01	21 : 00	PR Newswire (US)	I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023	NASDAQ:IMAB	I MAB
2023/10/16	21 : 00	PR Newswire (US)	I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023	NASDAQ:IMAB	I MAB
2023/10/11	00 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2023/10/10	21 : 24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

Vontobel Financial Produ...

DokiDoki.Chainbinders

NLBNPIT1XD67 20991231 10...

Societe Generale Effekten

BNP Paribas Issuance

NLBNPIT1YT01 20240621 14

Intesa Sanpaolo

Bnp Paribas Issuance

Vontobel Financial Produ...

IT0005589657 20240920 31...

BNP Paribas Issuance

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約